Case Study

Nanosuspension Formulation To Maximize Potency For Preclinical Studies

Source: Altasciences
GettyImages-1293773578 Scientist Using Pipette In Medical Development Lab

A client engaged Altasciences to leverage their proactive drug development approach to expedite the preclinical development of their new active pharmaceutical ingredient (API). Their objective was to create a robust formulation with maximum potency, requiring the development of a stable and effective drug prototype from scratch. Our team proposed a comprehensive study to conceptualize, optimize, and produce a formulation that would meet the rigorous requirements for clinical trials.

This approach not only ensured the rapid progression of the API through the preclinical phase but also laid a strong foundation for its success in subsequent clinical studies, aligning with the client's goal of achieving a high-quality, stable formulation.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online